FDA Urges Infant Formula Manufacturers to Strengthen Supplier Oversight

The U.S. Food and Drug Administration has issued a letter to infant formula manufacturers, emphasizing the need for improved oversight of their supply chains. This directive comes after several product recalls and the first infant botulism cases linked to formula in nearly five decades. The FDA expects companies to thoroughly understand the origins, production processes, and potential risks associated with all their ingredients to ensure product safety.